FDA.reportPublic FDA data

Nizoral Psoriasis Relief

Manufacturer
Kramer Laboratories
Effective date
2025-12-23
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 01:28:21

Label at a glance#

ProductNizoral Psoriasis Relief
Active ingredientSalicylic Acid
Label structure12 sections

Indications and uses

for the relief of itching, scaling, redness, flaking, and irritation associated with psoriasis helps prevent recurrence of psoriasis symptoms

Dosage and administration

apply to affected areas one to four times daily or as directed by a doctor

Storage and handling

store product at 20-25°C (68-77°F) keep carton for full product information.

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredientPurpose
Salicylic Acid 3.0%Psoriasis

Uses

INDICATIONS & USAGE SECTION

  • for the relief of itching, scaling, redness, flaking, and irritation associated with psoriasis
  • helps prevent recurrence of psoriasis symptoms

WARNINGS SECTION

Warnings
For external use only

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • condition covers a large area of the body

When using this product

OTC - WHEN USING SECTION

  • Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask doctor if

OTC - STOP USE SECTION

  • condition worsens or does not improve after regular use of this product as directed

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • apply to affected areas one to four times daily or as directed by a doctor

Other information

STORAGE AND HANDLING SECTION

  • store product at 20-25°C (68-77°F)
  • keep carton for full product information.

Inactive ingredients

INACTIVE INGREDIENT SECTION

allantoin, arachidyl alcohol, arachidyl glucoside, beeswax, behenyl alcohol, benzyl alcohol, butyrospermum parkii(shea) butter, cetearyl alcohol, chlorphenesin, cyclopentasiloxane, dimethicone, disodium EDTA, ethylhexyl isononanoate, glyceryl stearate, hydrogenated polydecene, isododecane, isosorbide dicaprylate, laureth-4, laureth-23, panthenol, PEG-100 stearate, PEG-7 trimethylolpropane coconut ether, propylene glycol, sodium hydroxide, tocopheryl acetate, water, xanthan gum

OTC - QUESTIONS SECTION

Questions? 1-800-824-4894

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEW

Nizoral®

Psoriasis
Relief Cream
SALICYLIC ACID 3%

For Psoriasis Affected Skin

RELIEVES
Itching, Irritation & Redness

CONTROLS
Flaking & Scaling

HELPS PREVENT
Recurrence of
Psoriasis Symptoms

FAST-ACTING
Starts Working from First Use

Free of Fragrance, Steroids,
Dyes & Parabens

Net wt 4 oz (113 g)

Specially
formulated
with:
√  Shea Butter
√  Vitamin B5
√  Vitamin E

Free of:
Ⅹ  Steroids
Ⅹ  Fragrances
Ⅹ  Dyes
Ⅹ  Parabens

Before use, read all label
information. If you have
a drug reaction, contact
a doctor and report it by
calling:
1.800.824.4894

Distributed by:
Kramer Laboratories, Inc.
Bridgewater, NJ 08807 
USA

© 2023 KRAMER
LABORATORIES, INC.

K0723

Carton Label
Carton Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
416910salicylic acid 3 % Topical CreamPSN3
416910salicylic acid 30 MG/ML Topical CreamSCD3
416910salicylic acid 3 % Topical CreamSY3

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55505-224-33Nizoral Psoriasis Relief113 g in 1 JARCREAM1133
55505-224-33Nizoral Psoriasis Relief1 in 1 CARTONCREAM13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55505-22455505-224-33

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 27 matching rows.

Name, UNII, Kind table
NameUNIIKind
Salicylic AcidO414PZ4LPZACTIB
Allantoin344S277G0ZIACT
Arachidyl Alcohol1QR1QRA9BUIACT
Arachidyl Glucoside6JVW35JOOJIACT
Yellow Wax2ZA36H0S2VIACT
Benzyl AlcoholLKG8494WBHIACT
Shea ButterK49155WL9YIACT
Cetostearyl Alcohol2DMT128M1SIACT
ChlorphenesinI670DAL4SZIACT
Cyclomethicone 50THT5PCI0RIACT
Dimethicone92RU3N3Y1OIACT
Disodium Edta-Copper6V475AX06UIACT
Edetate Disodium Anhydrous8NLQ36F6MMIACT
Glyceryl Stearate CitrateWH8T92A065IACT
Hydrogenated Polydecene Type IU333RI6EB7IACT
IsododecaneA8289P68Y2IACT
Isosorbide Dicaprylate0IK29C4889IACT
Laureth-46HQ855798JIACT
Laureth-23N72LMW566GIACT
PanthenolWV9CM0O67ZIACT
Peg-100 StearateYD01N1999RIACT
Peg-7 Trimethylolpropane Coconut EtherMVJ3AD73GGIACT
Propylene Glycol6DC9Q167V3IACT
Sodium Hydroxide55X04QC32IIACT
.Alpha.-Tocopherol Acetate9E8X80D2L0IACT
Water059QF0KO0RIACT
Xanthan GumTTV12P4NEEIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Nizoral Psoriasis ReliefSALICYLIC ACIDKramer Laboratories3f8bc77e-a5cf-469c-9733-22d3de33ef5a2025-12-23WarningsExact identifier
ndc (package): 55505-224-33
ndc (product): 55505-224
ndc11 (package): 55505022433
spl id: f8bafcbe-e409-4856-aa03-c47357259639
spl set id: 3f8bc77e-a5cf-469c-9733-22d3de33ef5a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.